SEARCH

SEARCH BY CITATION

References

  • 1
    AOA fact sheet. Washington, DC: American Obesity Association. Available at: http://www.obesity.org/subs/fastfacts/obesity_US.shtml. Accessed August 2004.
  • 2
    Flier JS. Obesity. In: BraunwaldE, FauciAS, IsselbacherKJ, KasperDL, HauserSL, LongoDL, et al., eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 2001: 479485.
  • 3
    Mezey E. Fatty Liver. In: SchiffER, SorrellMF, MaddreyWC, eds. Schiff's Diseases of the Liver. Philadelphia: Lippincott-Raven, 1999: 11851197.
  • 4
    Fausto N. Liver regeneration. In: AriasIM, BoyerJL, ChisariFV, FaustoN, SchachterD, ShafritzDA, eds. The Liver: Biology and Pathobiology. Philadelphia: Lippincott Williams & Wilkins, 2001: 591610.
  • 5
    Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292298.
  • 6
    Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, et al. Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 1989; 47: 903905.
  • 7
    Trevisani F, Colantoni A, Caraceni P, Van Thiel DH. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol 1996; 24: 114121.
  • 8
    Selzner M, Clavien P-A. Failure of regeneration in the steatotic rat liver: Disruption at two different levels in the regeneration pathway. HEPATOLOGY 2000; 31: 3542.
  • 9
    Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. HEPATOLOGY 2001; 34: 694706.
  • 10
    Cressman DE, Greenbaum LE, Haber BA, Taub R. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J Biol Chem 1994; 269: 3042930435.
  • 11
    Kirillova I, Chaisson M, Fausto N. Tumor necrosis factor induces DNA replication in hepatic cells through nuclear factor kappa B activation. Cell Growth Differ 1999; 10: 819828.
  • 12
    Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Schoonhoven R, Grisham JW, et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 1998; 101: 802811.
  • 13
    Plumpe J, Malek NP, Bock CT, Rakemann T, Manns MP, Trautwein C. NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol 2000; 278: G173G183.
  • 14
    Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A, et al. NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol 1998; 275: C1058C1066.
  • 15
    Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997; 94: 14411446.
  • 16
    Higgins GM, Anderson RM. Experimental pathology of the liver: I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186202.
  • 17
    DeAngelis RA, Kovalovich K, Cressman DE, Taub R. Normal liver regeneration in p50/nuclear factor kappaB1 knockout mice. HEPATOLOGY 2001; 33: 915924.
  • 18
    Markiewski MM, Mastellos D, Tudoran R, DeAngelis RA, Strey CW, Franchini S, et al. C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol 2004; 173: 747754.
  • 19
    Greenbaum LE, Li W, Cressman DE, Peng Y, Ciliberto G, Poli V, et al. CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest 1998; 102: 9961007.
  • 20
    Mohn KL, Laz TM, Hsu JC, Melby AE, Bravo R, Taub R. The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol Cell Biol 1991; 11: 381390.
  • 21
    Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6- deficient mice. Science 1996; 274: 13791383.
  • 22
    Gorski K, Carneiro M, Schibler U. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 1986; 47: 767776.
  • 23
    Wagner BJ, Hayes TE, Hoban CJ, Cochran BH. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 1990; 9: 44774484.
  • 24
    Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 6066.
  • 25
    Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 1999; 19: 26902698.
  • 26
    Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, et al. Interleukin 6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003; 278: 1128111288.
  • 27
    Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 1994; 10: 405455.
  • 28
    Libermann TA, Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990; 10: 23272334.
  • 29
    Day CP, James OF. Hepatic steatosis: innocent bystander or guilty party? HEPATOLOGY 1998; 27: 14631466.
  • 30
    Uchino S, Yamaguchi Y, Furuhashi T, Wang FS, Zhang JL, Okabe K, et al. Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats. J Surg Res 2004; 120: 7382.
  • 31
    Mayeux PR. Pathobiology of lipopolysaccharide. J Toxicol Environ Health 1997; 51: 415435.
  • 32
    Yamakawa T, Tanaka S, Yamakawa Y, Kiuchi Y, Isoda F, Kawamoto S, et al. Augmented production of tumor necrosis factor-alpha in obese mice. Clin Immunol Immunopathol 1995; 75: 5156.
  • 33
    Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997; 94: 25572562.
  • 34
    Cornell RP. Gut-derived endotoxin elicits hepatotrophic factor secretion for liver regeneration. Am J Physiol 1985; 249: R551R562.
  • 35
    Taub R. Liver regeneration in health and disease. Clin Lab Med 1996; 16: 341360.
  • 36
    Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995; 1: 13111314.
  • 37
    Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 5765.
  • 38
    Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004; 5: 836847.
  • 39
    Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 1997; 26: 4353.
  • 40
    Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G. The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol 2001; 80: 554561.
  • 41
    Farrell GC, Robertson GR, Leclercq I, Horsmans Y. Liver regeneration in obese mice with fatty livers: does the impairment have relevance for other types of fatty liver disease? HEPATOLOGY 2002; 35: 731732.
  • 42
    Zhang BH, Weltman M, Farrell GC. Does steatohepatitis impair liver regeneration? A study in a dietary model of non-alcoholic steatohepatitis in rats. J Gastroenterol Hepatol 1999; 14: 133137.
  • 43
    Picard C, Lambotte L, Starkel P, Sempoux C, Saliez A, Van den Berge V, et al. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats. J Hepatol 2002; 36: 645652.
  • 44
    Abanobi SE, Lombardi B, Shinozuka H. Stimulation of DNA synthesis and cell proliferation in the liver of rats fed a choline-devoid diet and their suppression by phenobarbital. Cancer Res 1982; 42: 412415.
  • 45
    Sesca E, Chiara M, Binasco V, Tessitore L. The delay in rat liver regeneration by choline is associated to alteration in c-myc expression. Boll Soc Ital Biol Sper 1996; 72: 217222.
  • 46
    Rao MS, Reddy JK. The effect of microvesicular fatty change on liver regeneration after partial hepatectomy. Hepatogastroenterology 2000; 47: 912915.
  • 47
    Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia 1986; 29: 192198.
  • 48
    Storlien LH, Pan DA, Kriketos AD, Baur LA. High fat diet-induced insulin resistance. Lessons and implications from animal studies. Ann N Y Acad Sci 1993; 683: 8290.
  • 49
    Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005; 11: 183190.
  • 50
    Birkhahn RH, Awad S, Thomford NR. Parenteral monoacetoacetin and liver regeneration interaction after partial hepatectomy in the rat. JPEN J Parenter Enteral Nutr 1994; 18: 219224.